What is the common factor that accounts for the United States having one of the highest COVID death rates in the world? Many less affluent countries have death rates 20 times lower than the U.S., even with fewer hospitals, doctors, nurses and high tech equipment than we have in the U.S.
It is quite simply this: EARLY OUTPATIENT TREATMENT at home with widely available anti-viral medicines, is begun at the first signs of symptoms, usually without waiting extra days for test results to confirm the physicians’ clinical diagnosis. Visiting health workers take the medicines to the patient at home, and instruct on how to take them.
Dr. Fauci and FDA’s Dr. Hahn have promoted a LATE STAGE treatment model for the U.S. Patients are sent home to self-quarantine until symptoms get worse, and then are told to go into the hospital when they are seriously ill with respiratory distress and even heart damage. Only at this critical illness stage⏤when our medicines don’t work as well⏤do patients get offered medication, oxygen support, steroids, anti-coagulants, vitamin C and other interventions.
But treatment at home could prevent thousands of hospitalizations and deaths. The United States urgently needs to reverse course and implement this new model using the successful early, outpatient, home-based treatment model successfully used in multiple other countries. In a just-published article from the respected American Journal of Medicine, lead author Peter McCullough, M.D., a cardiologist at Baylor, and one of the most widely published physicians in America, and describes how he and others are actually treating COVID patients successfully using this early treatment model.
Dr. McCullough’s recommendation for America to shift to outpatient, early treatment would clearly save lives using cheap, safe, FDA-approved medicines—hydroxychloroquine with azithromycin or doxycycline, possibly ivermectin or colchicine, inhaled budesomide or oral steroids, home oxygen concentrators, plus supplemental zinc, vitamin C and vitamin D. 
The supply of HCQ has been ramped up to handle its use in early treatment of COVID, but we have millions of doses in the Strategic National Stockpile deteriorating in government warehouses—vital medicine that is not being distributed because, for political reasons, doctors are still prevented from prescribing for COVID-19 outpatients.
Why don’t Americans have the freedom to use HCQ as in other countries?